MedPath

Efficacy and Safety of InSan Bamboo Salt on Improvement of Helicobacter Pylori Infection

Not Applicable
Completed
Conditions
Helicobacter Pylori Infection
Interventions
Dietary Supplement: InSan Bamboo Salt
Dietary Supplement: Placebo
Registration Number
NCT01735136
Lead Sponsor
Chonbuk National University Hospital
Brief Summary

The investigators performed a 4-week, randomized, double-blind, placebo-controlled human trial to evaluate the efficacy and safety of InSan Bamboo Salt on improvement of Helicobacter pylori infection. The investigators measured improvement of Helicobacter pylori infection parameters , including 14C-UBT(Urea breath test), and subjects' symptoms, and monitored their blood pressure.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Males and females 19-65 years old
  • 14C-UBT test ≥ 100 cpm
  • Endoscopy results showing gastritis
  • Able to give informed consent
Exclusion Criteria
  • Diagnosed of gastrointestinal disease such as ulcer, cancer, more than 10 erosions
  • Taken antibiotics and stomach medicines such as steroid, bismuth compound, H2-receptor antagonist and proton pump inhibitor within 2 weeks
  • Allergic or hypersensitive to any of the ingredients in the test products
  • History of reaction to any of the test products or of gastrointestinal diseases such as Crohn's disease or gastrointestinal surgery
  • History of alcohol or substance abuse
  • Participation in any other clinical trials within past 2 months
  • Laboratory test, medical or psychological conditions deemed by the investigators to interfere with successful participation in the study
  • Pregnant or lactating women etc.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
InSan Bamboo SaltInSan Bamboo Salt-
PlaceboPlacebo-
Primary Outcome Measures
NameTimeMethod
Changes in 14C-UBT(Urea breath test)4 weeks

14C-UBT(Urea breath test) was measured in study visit 1(0 week) and visit 3(4 week).

Secondary Outcome Measures
NameTimeMethod
Changes in subjects' symptoms4 weeks

subjects' symptoms was measured in study visit 1(0 week) and visit 3(4 week).

Trial Locations

Locations (1)

Clinical Trial Center for Functional Foods; Chonbuk National University Hospital

🇰🇷

Jeonju, Jeollabuk-do, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath